top of page

Aspiring to Improve Patients' Lives

NEXT- GENERATION THERAPEUTICS FOR INFLAMMATORY DISEASES

NEXT- GENERATION THERAPEUTICS FOR INFLAMMATORY DISEASES

Aspiring to Improve Patients' Lives

Latest News

April 23, 2026

Connect Biopharma Announces Enrollment in Phase 2 Seabreeze STAT Studies Will Continue as Planned Following Pre-Specified Interim Analysis

March 31, 2026

Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update

March 30, 2026

Rademikibart Demonstrates Best-in-Class Potential in Phase 3 Atopic Dermatitis Study

See all press releases >>

bottom of page